Article

Pattern of Use and Efficacy of Daratumumab-based Therapy in Patients With Multiple Myeloma in a Real-world Setting: a Single Institution Experience

2021-06-10

Abstract excerpt

<title>Abstract</title> <p><bold><italic>Purpose: </italic></bold>Multiple myeloma (MM) is an incurable hematologic malignancy, caused by the accelerated growth of clonal plasma cells leading to severe multiorgan failure. Several novel agents have been recently approved for the treatment of this diseases, including daratumumab, a human IgG kappa monoclonal antibody that targets CD38 on the surface of plasma cells...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fc3ebf9d-30ac-5ae6-bcf5-f8a319e7be16
DOI: 10.21203/rs.3.rs-597058/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pattern of Use and Efficacy of Daratumumab-based Therapy in Patients With Multiple Myeloma in a Real-world Setting: a Single Institution ExperienceDOI 10.21203/rs.3.rs-597058/v1Read

Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal AntibodySemantic proximity Read

Targeting CD38 with Daratumumab Monotherapy in Multiple MyelomaSemantic proximity Read

Potential role of daratumumab in the treatment of multiple myelomaSemantic proximity Read

Impact of Daratumumab in Transplant Eligible/Ineligible Patients with Newly Diagnosed Multiple Myeloma: An Updated Meta-Analysis of Phase- III TrialsSemantic proximity Read

Treatment outcome of newly diagnosed multiple myeloma patients: A retrospective analysis in a resource-limited settingSemantic proximity Read

Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literatureSemantic proximity Read

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaSemantic proximity Read

Multiple myeloma.Semantic proximity Read

Challenges, Difficulties, and Delayed Diagnosis of Multiple MyelomaSemantic proximity Read

Perspectives on Drug Development in Multiple Myeloma-Looking Forward to 2025.Semantic proximity Read

Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group databaseSemantic proximity Read

Multiple myeloma: patient outcomes in real-world practice.Semantic proximity Read